Diagnosis of Trichomonas vaginalis infection in male or female patients.
Trichomonas vaginalis is the most common curable sexually transmitted disease (STD) agent in the U.S. It causes vaginitis, urethritis, pelvic inflammatory disease, preterm births, low-birth-weight infants, and increased risk of HIV transmission.
Due to the high prevalence of T. vaginalis in all female age groups, it is suggested that both symptomatic and asymptomatic women who are screened for Chlamydia trachomatis and Neisseria gonorrhoeae should also be screened for T. vaginalis.
Urine collections:
Vaginal swab specimens:
Aptima Multitest swab specimen collection kit
Direct patient to provide first-catch urine (approximately 20 to 30 mL of initial urine stream) into urine collection cup free of any preservatives. Collection of larger volumes of urine may result in specimen dilution that may reduce test sensitivity.
Swab:
Ambient - 60 days
Refrigerated - 60 days
Urine:
Ambient - 30 days
Refrigerated - 30 days
Target capture with transcription-mediated amplification
Negative
Aptima Trichomonas Female Assay Performance |
||
Specimen Type |
Sensitivity |
Specificity |
Vaginal Swab Asymptomatic |
100% |
98.9% |
Urine Asymptomatic |
95.5% |
99.0% |
Overall Asymptomatic |
98.4% |
99.7% |
Vaginal Swab Symptomatic |
100% |
99.1% |
Urine Symptomatic |
95.2% |
98.9% |
Symptomatic Overall |
98.4% |
99.1% |
Aptima Trichomonas Male Urine Assay Performance |
||
|
Sensitivity |
Specificity |
Symptomatic |
100% |
99.7% |
Asymptomatic |
100% |
99.9% |
Overall |
100% |
99.8% |